Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid exposure to bictegravir/emtricitabine/tenofovir in HIV-1-infected patients with CNS impairment
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-09-08
DOI
10.1093/jac/dkab334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Failure to Biktarvy® and development of resistance mutations in an antiretroviral-experienced patient
- (2020) Ana Belén Lozano et al. ANTIVIRAL RESEARCH
- Increased age and male sex are independently associated with higher frequency of blood–cerebrospinal fluid barrier dysfunction using the albumin quotient
- (2020) Massimiliano Castellazzi et al. Fluids and Barriers of the CNS
- Effect of ageing on antiretroviral drug pharmacokinetics using clinical data combined with modelling and simulation
- (2020) Felix Stader et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Antiretroviral drug concentrations in brain tissue of adult decedents
- (2020) Micol Ferrara et al. AIDS
- Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV
- (2020) Andrea Calcagno et al. CLINICAL PHARMACOKINETICS
- Characteristics of Dolutegravir and Bictegravir Plasma Protein Binding: a First Approach for the Study of Pharmacologic Sanctuaries
- (2020) Thibaut Gelé et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS 62)
- (2020) Juan M Tiraboschi et al. JOURNAL OF INFECTIOUS DISEASES
- Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species
- (2019) Corbin G. Thompson et al. Science Translational Medicine
- Dolutegravir Cerebrospinal Fluid Diffusion in HIV-1–Infected Patients with Central Nervous System Impairment
- (2019) Thibaut Gelé et al. Open Forum Infectious Diseases
- Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid
- (2019) Qing Ma et al. CLINICAL INFECTIOUS DISEASES
- Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56)
- (2019) Juan Tiraboschi et al. JOURNAL OF INFECTIOUS DISEASES
- Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
- (2019) Scott L Letendre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- UPLC–MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma
- (2019) Hélène Gouget et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2018) Michael S. Saag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults
- (2017) Joel E. Gallant et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
- (2017) Joel Gallant et al. LANCET
- Mechanisms of CNS Viral Seeding by HIV + CD14 + CD16 + Monocytes: Establishment and Reseeding of Viral Reservoirs Contributing to HIV-Associated Neurocognitive Disorders
- (2017) Mike Veenstra et al. mBio
- Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
- (2017) Adam Trickey et al. Lancet HIV
- Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile
- (2016) Manuel Tsiang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Persistent HIV-1 replication maintains the tissue reservoir during therapy
- (2016) Ramon Lorenzo-Redondo et al. NATURE
- HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment
- (2016) Deanna Saylor et al. Nature Reviews Neurology
- ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1-Infected, Antiretroviral Therapy-Naive Subjects
- (2014) S. L. Letendre et al. CLINICAL INFECTIOUS DISEASES
- Protein-Free Efavirenz Concentrations in Cerebrospinal Fluid and Blood Plasma Are Equivalent: Applying the Law of Mass Action To Predict Protein-Free Drug Concentration
- (2013) L. B. Avery et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
- (2013) Peter J. Ruane et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Etravirine in CSF is highly protein bound
- (2013) A. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340,In Vitro
- (2012) Eve-Irene Lepist et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir
- (2012) Brookie M. Best et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration
- (2012) D. Croteau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection
- (2012) Victor Valcour et al. JOURNAL OF INFECTIOUS DISEASES
- Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage
- (2011) Andrea Calcagno et al. AIDS
- Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants
- (2011) Patricia M. Flynn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1
- (2010) D. Croteau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
- (2008) Scott Letendre ARCHIVES OF NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now